Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 27, 2018
Helsinn and Menarini announced that Berlin Chemie AG, the German company of the Menarini Group, has been granted exclusive licensing rights to commercialize Pracinostat worldwide.
read more
Heidelberg has signed a Master Service Agreement with ProBioGen for the antibodies used in two of their pipeline ATAC molecules.
read more
HedgePath Pharmaceuticals (HPPI) has entered into a definitive agreement with an affiliate of Mayne Pharma Group Limited under which Mayne Pharma will invest $2.5M in HPPI in a private common stock and warrant financing.
read more
Albumedix and Hebei Changshan Biochem Pharma Co., Ltd (Changshan) today announced that they have entered into a supply agreement for the development of a novel type II diabetes treatment that enables once-weekly dosing.
read more
Heat Biologics, Inc. announced a planned development partnership of its Scorpion Biological Services subsidiary with a private developer, the State of Kansas and local and university affiliates, to support the development of a new biodefense-focused ...
read more
Heat Biologics, Inc. has unveiled enhanced allogeneic cell therapy manufacturing capabilities through its Scorpion Biological Services subsidiary.
read more
Heat Biologics, Inc. is changing the name of the company to NightHawk Biosciences, Inc., effective May 3, 2022, to better reflect the Company’s evolution, including expansion of its therapeutic pipeline, the vertical integration of capabilities from ...
read more
Tuesday, December 21, 2021
Heat Biologics, Inc. a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, has executed a definitive merger agreement to acquire Elusys Therapeutics, a commercial-stage biodefense ...
read more
Heat Biologics, a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announced the launch of its wholly-owned subsidiary, Skunkworx Bio, Inc. (“Skunkworx”), focused on the ...
read more
Heat Biologics Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced it will be hosting a groundbreaking ceremony for the launch of its new planned San Antonio ...
read more
Wednesday, October 26, 2016
Heat Biologics a developer of gp96-based immunotherapies that activate a patient’s immune system to fight cancer, announced that it has entered into an agreement with the University of Miami for the license and development of a portfolio of patents ...
read more
HealthVerity announced that it has been awarded a contract with the Centers for Disease Control and Prevention (CDC) to provide a large-scale, fully interoperable, real-world dataset to advance a wide range of COVID-19 research, decision making, and ...
read more
HealthVerity has signed a multi-year Research Collaboration Agreement with the FDA to evaluate a range of different real-world datasets for their potential to inform the FDA's response to COVID-19.
read more
Friday, November 01, 2019
HealthTrust has awarded a 36-month group purchasing agreement effective November 1, 2019 for EcoVue ultrasound gel to York, Pennsylvania based HR Pharmaceuticals.
read more
HealthCore, Inc. will collaborate with PCORnet, the National Patient-Centered Clinical Research Network, on building a sustainable patient-centered outcomes research network to conduct real-world comparative effectiveness research as part of a ...
read more